Boron Agent Delivery Platforms Based on Natural Products for Boron Neutron Capture Therapy

被引：0

作者：

Kawasaki, Riku ^{[1
]}

Miura, Yamato ^{[1
]}

Kono, Nanami ^{[1
]}

Fujita, Seiya ^{[1
]}

Yamana, Keita ^{[1
]}

Ikeda, Atsushi ^{[1
]}

机构：

[1] Hiroshima Univ, Grad Sch Adv Sci & Engn, Program Appl Chem, 1-4-1 Kagamiyama, Hiroshima 7398527, Japan

来源：

CHEMMEDCHEM | 2024年 / 19卷 / 21期

基金：

日本学术振兴会;

关键词：

Boron neutron capture therapy; natural based products; drug delivery system; supramolecular chemistry; SELF-ASSEMBLED NANOGELS; DRUG-DELIVERY; HYDROXYPROPYL CELLULOSE; PHOTODYNAMIC ACTIVITIES; WATER SOLUBILIZATION; CARBORANE; DERIVATIVES; SYSTEM; LIPOSOMES; EXOSOME;

D O I：

10.1002/cmdc.202400323

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Boron neutron capture therapy (BNCT) is one of the most promising modalities for cancer treatment due to its minimal invasiveness. Although two types of boron agents are clinically used, several issues persist in their delivery, including poor water solubility, instability in aqueous media, selectivity toward cancer cells, accumulation in cancer cells, retention time in tumor tissue, and efficiency in achieving the boron neutron capture reaction. Addressing these challenges, numerous groups have explored various boron agents to enhance the therapeutic benefits of BNCT. This review summarizes delivery platforms based on natural products for BNCT. In this review, delivery platforms for boron agents using natural products including lipids, polysaccharides, polypeptides, and extracellular vesicle for boron neutron capture therapy were summarized. These nanosystems enabled to enhance deliverability of boron agents to tumor tissues with high specificity, resulting in therapeutic benefits of boron neutron capture therapy are enhanced. image

引用

页数：9

共 50 条

[31] Accelerator-based neutron source for boron neutron capture therapy
Ivanov, A. A.
Smirnov, A. N.
Taskaev, S. Yu
Bayanov, B. F.
Belchenko, Yu, I
Davydenko, V., I
Dunaevsky, A.
Emelev, I. S.
Kasatov, D. A.
Makarov, A. N.
Meekins, M.
Kuksanov, N. K.
Popov, S. S.
Salimov, R. A.
Sanin, A. L.
Sorokin, I. N.
Sycheva, T., V
Shudlo, I. M.
Vorob'ev, D. S.
Cherepkov, V. G.
Fadeev, S. N.
PHYSICS-USPEKHI, 2022, 65 (08) : 834 - 851
[32] Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2
Wongthai, Printip
Hagiwara, Kohei
Miyoshi, Yurika
Wiriyasermkul, Pattama
Wei, Ling
Ohgaki, Ryuichi
Kato, Itsuro
Hamase, Kenji
Nagamori, Shushi
Kanai, Yoshikatsu
CANCER SCIENCE, 2015, 106 (03) : 279 - 286
[33] Utilizing neutron generators in boron neutron capture therapy
Metwally, Walid A.
Adel, Yumna
Dalah, Entesar Z.
Al-Omari, Husam
APPLIED RADIATION AND ISOTOPES, 2021, 174
[34] Design of a neutron target for boron neutron capture therapy
Wang J.
Kong H.
Li D.
He Jishu/Nuclear Techniques, 2024, 47 (04):
[35] Boron neutron capture therapy for glioblastoma: improvement of boron biodistribution by hyaluronidase
Haselsberger, K
Radner, H
Pendl, C
CANCER LETTERS, 1998, 131 (01) : 109 - 111
[36] Intratumoral Transforming Boron Nanosensitizers for Amplified Boron Neutron Capture Therapy
Li, Liping
Wang, Mixue
Zhao, Qian
Bai, Peirong
Hao, Haotian
Zhang, Zizhu
Liu, Tong
Yang, Yongzhen
Pu, Kanyi
Zhang, Ruiping
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2024,
[37] The Development of Boron Analysis and Imaging in Boron Neutron Capture Therapy (BNCT)
Dai, Qi
Yang, QiYao
Bao, Xiaoyan
Chen, Jiejian
Han, Min
Wei, Qichun
MOLECULAR PHARMACEUTICS, 2022, 19 (02) : 363 - 377
[38] A Critical Assessment of Boron Target Compounds for Boron Neutron Capture Therapy
M. Frederick Hawthorne
Mark W. Lee
Journal of Neuro-Oncology, 2003, 62 : 33 - 45
[39] A critical assessment of boron target compounds for boron neutron capture therapy
Hawthorne, MF
Lee, MW
JOURNAL OF NEURO-ONCOLOGY, 2003, 62 (01) : 33 - 45
[40] Boron neutron capture therapy assisted by boron-conjugated nanoparticles
Shogo Sumitani
Yukio Nagasaki
Polymer Journal, 2012, 44 : 522 - 530

← 1 2 3 4 5 →